Literature DB >> 1486898

Use of fluconazole in the treatment of Candida albicans hydrocephalus shunt infection.

M Cruciani, G Di Perri, M Molesini, S Vento, E Concia, D Bassetti.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1486898     DOI: 10.1007/bf01962387

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  5 in total

1.  Hydrocephalus shunt infections and their treatment.

Authors:  R Bayston
Journal:  J Antimicrob Chemother       Date:  1985-03       Impact factor: 5.790

2.  Oral fluconazole as suppressive therapy of disseminated cryptococcosis in patients with acquired immunodeficiency syndrome.

Authors:  A M Sugar; C Saunders
Journal:  Am J Med       Date:  1988-10       Impact factor: 4.965

Review 3.  Candida albicans shunt infection.

Authors:  S Shapiro; T Javed; J Mealey
Journal:  Pediatr Neurosci       Date:  1989

4.  Parkinsonism associated with intraventricular amphotericin B.

Authors:  J F Fisher; J Dewald
Journal:  J Antimicrob Chemother       Date:  1983-07       Impact factor: 5.790

Review 5.  Antifungal therapy and the new azole compounds.

Authors:  R J Hay
Journal:  J Antimicrob Chemother       Date:  1991-07       Impact factor: 5.790

  5 in total
  3 in total

Review 1.  Antifungal agents in neonatal systemic candidiasis.

Authors:  J N van den Anker; N M van Popele; P J Sauer
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191

Review 2.  Systemic fungal infections in neonates.

Authors:  P C Ng
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-09       Impact factor: 5.747

Review 3.  Safety of fluconazole in paediatrics: a systematic review.

Authors:  Oluwaseun Egunsola; Abiodun Adefurin; Apostolos Fakis; Evelyne Jacqz-Aigrain; Imti Choonara; Helen Sammons
Journal:  Eur J Clin Pharmacol       Date:  2013-01-17       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.